![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_8159b09a6bebd9e5751360e57f770ab8.svg) | Clozapine | IC50 | 58.0 [1], 120.0 [2], 138.0 [3], 156.0 [4], 168.0 [5] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_8159b09a6bebd9e5751360e57f770ab8.svg) | Clozapine | Ki | 28.4 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_7ce5c90b273b41810bee3170ac9401d3.svg) | Haloperidol | IC50 | 1.3 [1], 5.0 [2], 6.0 [3], 6.5 [4] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_7ce5c90b273b41810bee3170ac9401d3.svg) | Haloperidol | Ki | 2.3 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_14ad78f21aebf7ef75d24ea25f5fe082.svg) | 3-((4-(4-Chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo[2,3-b]pyridine | Ki | 0.43 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_4f1ecda65187979a1ede67e5fe1e057c.svg) | Quinpirole | Ki | 1.8 [1], 53.0 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_135e1b51c4285a8ab5ce02f8e0f91fbe.svg) | N-[4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butyl]-1-benzothiophene-2-carboxamide | Ki | 170.0 [1], 340.0 [2], 800.0 [3], 3600.0 [4] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_8b78ef0953132cb6729f40caa0d6bbea.svg) | Olanzapine | IC50 | 173.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_8b78ef0953132cb6729f40caa0d6bbea.svg) | Olanzapine | Ki | 28.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_be4565ca8c20c1d9804fa640fd1584d5.svg) | Risperidone | Ki | 6.2 [1], 7.0 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_d24fe0e15c6ed43cc236ee350bd5c850.svg) | Pramipexole | Ki | 8.1 [1], 130.0 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_bcbb36a6cad84298c3dc74af8f90788c.svg) | N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butyl)benzofuran-2-carboxamide | Ki | 93.0 [1], 320.0 [2], 890.0 [3], 5740.0 [4] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_c871e436119b1d6f92ea7571ed4647e5.svg) | Quetiapine | Ki | 1000.0 [1], 1600.0 [2], 2200.0 [3] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_6cf5ecbb9a1c42bdc42ce186d840229c.svg) | 2-Naphthalenecarboxamide, N-(4-(4-(2-methoxyphenyl)-1-piperazinyl)butyl)- | Ki | 38.9 [1], 39.0 [2], 44.0 [3], 300.0 [4] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_539379af00d28d52ac3e09d6c762f691.svg) | 3-(4-(4-Chlorophenyl-4-hydroxypiperidino)methyl)indole | Ki | 220.0 [1], 449.0 [2], 1100.0 [3], 1520.0 [4], 1520.7 [5] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_77e4af059cc4b18b86801899a8e5718a.svg) | CID 11477180 | Ki | 375.0 [1], 550.0 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_da9a9cc8e5c7237e38b5596d82a38c22.svg) | N-[4-[4-(2-Methoxyphenyl)piperazin-1-yl]butyl]pyrazolo[1,5-a]pyridine-2-carboxamide | Ki | 2.0 [1], 128.82 [2], 130.0 [3], 150.0 [4] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_c01a6b3d063d97c54b4faccdab41fca4.svg) | 5-(4-Chlorophenyl)-4-methyl-3-(1-(2-phenylethyl)piperidin-4-yl)isoxazole | Ki | 2.5 [1], 3.5 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_96a9bdb79c4ed0a3e31c53982f1e7a6f.svg) | 4-[3-(4-Chlorophenyl)-3-hydroxy-8-azabicyclo[3.2.1]oct-8-yl]-1-(4-fluorophenyl)butan-1-one | Ki | 5.3 [1], 11.75 [2], 12.0 [3] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_fe527898da428e93fb78fd0de1ee5dda.svg) | (4-Ethynyl-3-cyclohexenyl)dipropylamine | Ki | -0.69 [1], 22.0 [2], 38.0 [3], 170.0 [4], 380.0 [5] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_a51676f3b1baa84a1feba2f1a52c0a1c.svg) | N,N-Dipropyl-4-(2-trimethylsilylethynyl)cyclohex-3-en-1-amine | Ki | -0.76 [1], 54.0 [2], 160.0 [3], 640.0 [4], 3800.0 [5] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_f25dfa08591eac4ad2095b30ced84e29.svg) | Spiperone | IC50 | 0.5 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_f25dfa08591eac4ad2095b30ced84e29.svg) | Spiperone | Ki | 0.33 [1], 0.45 [2], 1.4 [3] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_1702ec4e91a6e6ac7ec0735114adb8a6.svg) | Ziprasidone | Ki | 32.0 [1], 39.0 [2], 50.12 [3] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_825e197d1852c3a39000b8e4f06fd573.svg) | Loxapine | IC50 | 14.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_825e197d1852c3a39000b8e4f06fd573.svg) | Loxapine | Ki | 4.9 [1], 9.0 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_e3362ea8542d8457f586c15ccf7112b2.svg) | N-[[4-(2-Cyanophenyl)piperazin-1-yl]methyl]-3-methylbenzamide | Ki | 8.7 [1], 8.71 [2], 9.0 [3], 16.98 [4] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_3f46f6bc77a0c33c9a5797ca9fe81d84.svg) | 1-[4-(4-Chlorobenzyl)piperazinoacetyl]indoline | IC50 | 1.6 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_3f46f6bc77a0c33c9a5797ca9fe81d84.svg) | 1-[4-(4-Chlorobenzyl)piperazinoacetyl]indoline | Ki | 1.6 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_421b8d1934e3715ea1028700fe65fa1f.svg) | N-(4-(4-(2-Methoxyphenyl)piperazin-1-yl)butyl)benzo[b]thiophene-2-carboxamide | Ki | 15.0 [1], 15.14 [2], 24.0 [3], 305.0 [4] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_bbe06f8fbcdad7156addc46c54182570.svg) | (2R)-1-[4-(4-Methylbenzyl)piperazinoacetyl]-2-methylindoline | IC50 | 2.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_bbe06f8fbcdad7156addc46c54182570.svg) | (2R)-1-[4-(4-Methylbenzyl)piperazinoacetyl]-2-methylindoline | Ki | 2.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_5e0d4c843131f068185294b41a13c5c4.svg) | (S)-7-Dipropylamino-5,6,7,8-tetrahydro-indolizine-3-carbaldehyde | Ki | 32.0 [1], 2500.0 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_a7e11d7bcee94c9af8c42c557a082c25.svg) | Chlorpromazine | Ki | 25.12 [1], 30.0 [2], 479.0 [3] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_e8138dcbce34118e33bd4b23c56e1801.svg) | (1S,2R)-5-Methoxy-1-methyl-N,N-dipropyl-1,2,3,4-tetrahydronaphthalen-2-amine | Ki | 48.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_f2c8cfca26d08d9cddd0a351dd654443.svg) | N-[4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butyl]-9H-fluorene-2-carboxamide | Ki | 3670.0 [1], 5000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_2b612bcb727b9057754ae9b825e61334.svg) | N-(2-[4-(4-Chlorophenyl)piperazin-1-yl]ethyl)-3-methoxybenzamide | IC50 | 0.06 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_2b612bcb727b9057754ae9b825e61334.svg) | N-(2-[4-(4-Chlorophenyl)piperazin-1-yl]ethyl)-3-methoxybenzamide | Ki | 0.04 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_76903c399ec600b9d6ed76fc0d032957.svg) | CID 11301655 | IC50 | 5.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_76903c399ec600b9d6ed76fc0d032957.svg) | CID 11301655 | Ki | 1.5 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_760c170bad01a1c163e866a9dbce9f05.svg) | N-(4-(4-(2-Methoxyphenyl)piperazin-1-yl)butyl)benzofuran-2-carboxamide | Ki | 30.0 [1], 30.2 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_755ee1e8383f829eee41205704ba0ef5.svg) | US8748608, 34 Enantiomer A | Ki | 2600.0 [1], 4900.0 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_f7df2687b6d970c8b6467ef5c111125e.svg) | 4-[4-(4-Chlorophenyl)piperazin-1-yl]-1-(4-fluorophenyl)butan-1-one | Ki | 7.6 [1], 17.0 [2], 17.5 [3] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_9b0637d04dce10bb2b262c4b3b0c3b07.svg) | 4-(3-(4-Chlorophenyl)-3-hydroxypyrrolidin-1-yl)-1-(4-fluorophenyl)butan-1-one | Ki | 3.6 [1], 11.0 [2], 245.0 [3] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_63496733a2ee7161ee3d52683fdaf225.svg) | N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)but-2-enyl)-9H-fluorene-2-carboxamide | Ki | 1020.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_42e3d71ce3ac9af8cb0ce37c1af31016.svg) | 1-Phenyl-4-((1-phenyl-1H-pyrazol-4-yl)methyl)piperazine | Ki | 1.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_f44ef5536c22efc31df5ce006f95b2b8.svg) | N-[4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butyl]-9-oxofluorene-4-carboxamide | Ki | 1116.0 [1], 1850.0 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_9b940f67351b5a2f268868da4b956d5e.svg) | N-[2-[4-(2-Methoxyphenyl)piperazin-1-yl]ethyl]pyrazolo[1,5-a]pyridine-3-carboxamide | Ki | 0.67 [1], 0.68 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_d70a81e024e37dc8dc5b94ad4f093ec9.svg) | N,N-Dimethyl-1-(3-oxa-2-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7,9,11,14,16-hexaen-4-yl)methanamine | IC50 | 131.83 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_3a810018733eff075ae6c928a1984e94.svg) | 3-(4-Benzyl-piperazin-1-yl)-phenol | Ki | 400.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_7c2b6b27c7beebc43c6fe87d4cc41d7b.svg) | 4-[5-(4-Chloro-phenyl)-1H-pyrazol-3-yl]-1-phenethyl-piperidine | Ki | 5.5 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_e2e71cf6d767ac32b328ff2fa0a77039.svg) | N-[3-[4-(2-Methoxyphenyl)piperazin-1-yl]propyl]pyrazolo[1,5-a]pyridine-3-carboxamide | Ki | 14.0 [1], 56.0 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_fca76485e17be803b3cb63e3f759826d.svg) | N-[(E)-4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]but-2-enyl]-1-benzofuran-2-carboxamide | Ki | 1070.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_fe04b3029d7911cfe55e9e41e406e397.svg) | 4-[5-(4-Chlorophenyl)-1H-pyrazol-3-yl]-1-[(4-chlorophenyl)methyl]piperidine | Ki | 61.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_09647dbcd0b940f9d555a16fc3b15737.svg) | N-[4-(2-Chloro-phenyl)-piperazin-1-ylmethyl]-benzamide | Ki | 32.0 [1], 32.36 [2], 107.15 [3] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_6e5151238393ad30c3896fb634c5f02a.svg) | N-[4-(2-Cyano-phenyl)-piperazin-1-ylmethyl]-4-methyl-benzamide | Ki | 1.2 [1], 6.46 [2], 6.5 [3] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_b8fc584eb7346f714d003297f6226eb6.svg) | N-[4-(2-Methoxy-phenyl)-piperazin-1-ylmethyl]-3-methyl-benzamide | Ki | 6.7 [1], 6.76 [2], 12.88 [3] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_3e7e9ff547f8e01a49d7581be4ace3dd.svg) | 3-Methoxy-N-(2-(4-(2-methoxyphenyl)piperazin-1-yl)ethyl)benzamide | IC50 | 1.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_3e7e9ff547f8e01a49d7581be4ace3dd.svg) | 3-Methoxy-N-(2-(4-(2-methoxyphenyl)piperazin-1-yl)ethyl)benzamide | Ki | 1.1 [1], 1.3 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_0b4ef09ff2057c7bffc88dc951f4b8d3.svg) | 1-(2-Methoxy-phenyl)-4-(1-phenyl-1H-pyrrol-3-ylmethyl)-piperazine | Ki | 0.7 [1], 1.3 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_e0683a4a06630fe12682f6e4fb3dfa14.svg) | 4-Chloro-N-[4-(2-methoxy-phenyl)-piperazin-1-ylmethyl]-benzamide | Ki | 3.47 [1], 14.0 [2], 14.13 [3] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_38b3c2a0128f5e91002cd7c3c3843591.svg) | N-[4-(2-Methoxy-phenyl)-piperazin-1-ylmethyl]-4-methyl-benzamide | Ki | 3.39 [1], 7.7 [2], 7.76 [3] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_be2c94c1bb3e8fadc5d20ca581122534.svg) | N-[4-(2-Methoxy-phenyl)-piperazin-1-ylmethyl]-benzamide | Ki | 21.88 [1], 22.0 [2], 30.9 [3] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_c1d5f3f96498b97474ad046e7ae31556.svg) | N-[4-(2-Chloro-phenyl)-piperazin-1-ylmethyl]-4-methyl-benzamide | Ki | 12.0 [1], 12.02 [2], 218.78 [3] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_2a207d0a2bcec4a0e611782b20ae3164.svg) | 3-Chloro-N-[4-(2-methoxy-phenyl)-piperazin-1-ylmethyl]-benzamide | Ki | 15.0 [1], 15.14 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_2f9ba05d8152d69eef2b33a8073f5e97.svg) | N-[4-(2-Chloro-phenyl)-piperazin-1-ylmethyl]-3-methyl-benzamide | Ki | 15.85 [1], 26.92 [2], 27.0 [3] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_99afe2e256ae4065405d6188e1c8acf0.svg) | 4-Chloro-N-[4-(2-chloro-phenyl)-piperazin-1-ylmethyl]-benzamide | Ki | 5.25 [1], 5.3 [2], 8.32 [3] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_066b473d711177dc17c434a496e95856.svg) | 4-Chloro-N-[4-(2-cyano-phenyl)-piperazin-1-ylmethyl]-benzamide | Ki | 3.89 [1], 5.5 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_c76e786f343b78f1afc50854e4bcb92b.svg) | Dipropyl-(S)-4,5,6,7-tetrahydro-pyrazolo[1,5-a]pyridin-5-yl-amine | Ki | 58.0 [1], 380.0 [2], 1700.0 [3] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_3c07893bc06f76ff642d7586f3efa157.svg) | 1-[4-(4-Methylbenzyl)piperazinoacetyl]-2-methylindoline | IC50 | 3.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_3c07893bc06f76ff642d7586f3efa157.svg) | 1-[4-(4-Methylbenzyl)piperazinoacetyl]-2-methylindoline | Ki | 3.0 [1], 7.0 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_aa73622658e07b164e3baca6e9903dd6.svg) | N-[4-(2-Cyano-phenyl)-piperazin-1-ylmethyl]-benzamide | Ki | 23.99 [1], 26.92 [2], 27.0 [3] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_9e6b755435e80fba7cb3656926f0c23d.svg) | 3-Chloro-N-[4-(2-cyano-phenyl)-piperazin-1-ylmethyl]-benzamide | Ki | 5.25 [1], 33.88 [2], 34.0 [3] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_4575b659776f2cd9f4796f1acce170b3.svg) | 1-Phenyl-4-((R)-2-phenyl-4,5-dihydro-1H-imidazol-4-ylmethyl)-piperazine; hydrochloride | Ki | 0.95 [1], 51.0 [2], 72.0 [3] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_b329cb5fecb003fb4c92d7c3545f5228.svg) | Mianserin | IC50 | 3311.31 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_112cb7603ef103663fb2d68ed01dbedd.svg) | Sertindole | Ki | 11.0 [1], 21.0 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_78556840523f6ddf93414d9893771b00.svg) | Remoxipride | IC50 | 3872.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_78556840523f6ddf93414d9893771b00.svg) | Remoxipride | Ki | 3872.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_6cb3ea27fe013e7dda2c01a588aff4ff.svg) | Zotepine | Ki | 39.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_ff8d4194409d8fceaa071169fcd4b4d4.svg) | GR-127935 | Ki | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_d980c64e2d7448368414af30c84b8a23.svg) | Levosulpiride | Ki | 2100.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_e73173f946f838886a8a4b331b7f2e1d.svg) | Ecopipam | Ki | 5515.0 [1], 5520.0 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_8873e7c98d1d6dd57f09c4a8cd059afc.svg) | Cariprazine | Ki | 110.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_27b8534df298602c72325f7a33709e46.svg) | Fananserin | Ki | 2.9 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_6ea3badef827d6aaa7c33ccf7d541765.svg) | 5-Methoxy-1-methyl-2-(n-propylamino)tetralin | Ki | 117.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_0ef8e49ad0f17d5eb8cd799eb0c079f1.svg) | 7-Methyl-6,7,8,9,14,15-hexahydro-5H-benz[d]indolo[2,3-g]azecine | Ki | 108.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_78e4c4c0fb3623b8bb29822812c181cc.svg) | Sonepiprazole | Ki | 3.6 [1], 6.8 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_9c0cd3025144fe3c33a11fe0f9a32d17.svg) | 2-[4-[(2-Phenyl-1H-imidazol-5-yl)methyl]piperazin-1-yl]pyrimidine | Ki | 3.6 [1], 3.8 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_566829bdab526f7ffb62ca959b5964f2.svg) | Tppcmp | Ki | 90.9 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_b5efeaa115315df07244ed46cdd7f242.svg) | 2-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e)(1,4)diazepine | IC50 | 110.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_b5efeaa115315df07244ed46cdd7f242.svg) | 2-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e)(1,4)diazepine | Ki | 16.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_fa42fcb09b23f0893739d9924da03651.svg) | 1-[(1-(4-Chlorophenyl)-1H-pyrazol-4-yl)methyl]-4-phenylpiperazine | Ki | 170.0 [1], 180.0 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_4b7113c45d88a59548f5c8655d232b40.svg) | L-745,870 Hydrochloride | IC50 | 5.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_4b7113c45d88a59548f5c8655d232b40.svg) | L-745,870 Hydrochloride | Ki | 0.43 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_0a134c7bdfe8bb6ecd77b0a4423ba759.svg) | (R)-N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)-3-hydroxybutyl)-1H-indole-2-carboxamide | Ki | 3430.0 [1], 4000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d4-receptor_fc8bdd1583fe377dfcd4f750b5c85857.svg) | N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butyl)-1H-indole-2-carboxamide | Ki | 800.0 [1], 1698.24 [2] |